Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Wascher

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Stroke|March 1, 2008
Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance testHarald Sourij, Isabella Schmoelzer, Peter Dittrich, et al.
Therapeutics and Clinical Risk Management|February 2, 2017
Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 DiabetesGuntram Schernthaner, Sarah Jarvis, Chaim Lotan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjectsOlaf Stanger, Hans-Juergen Semmelrock, Willibald Wonisch, et al.
Atherosclerosis|September 5, 2002
The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial diseaseWilfried Renner, Edmund Pabst, Bernhard Paulweber, et al.
European Journal of Endocrinology|February 25, 2021
The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortalityMartina Behanova, Judith Haschka, Jochen Zwerina, et al.
Thrombosis and Haemostasis|December 24, 2003
The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosisHerwig Köppel, Wilfried Renner, Alexander Gugl, et al.
Thrombosis and Haemostasis|June 4, 2004
Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial diseaseHerwig Köppel, Peter Krippl, Robert Gasser, et al.
Stroke|March 8, 2003
Associations of a human G protein beta3 subunit dimorphism with insulin resistance and carotid atherosclerosisThomas C Wascher, Bernhard Paulweber, Liliane Malaimare, et al.
Diabetes Care|June 28, 2006
Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-alpha antibody infliximab: a case observationBabak Yazdani-Biuki, Thomas Mueller, Hans-Peter Brezinschek, et al.
International Journal of Cardiology|January 3, 2009
Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose toleranceSabine Perl, Isabella Schmölzer, Harald Sourij, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Stroke|March 1, 2008
Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance testHarald Sourij, Isabella Schmoelzer, Peter Dittrich, et al.
Therapeutics and Clinical Risk Management|February 2, 2017
Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 DiabetesGuntram Schernthaner, Sarah Jarvis, Chaim Lotan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjectsOlaf Stanger, Hans-Juergen Semmelrock, Willibald Wonisch, et al.
Atherosclerosis|September 5, 2002
The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial diseaseWilfried Renner, Edmund Pabst, Bernhard Paulweber, et al.
European Journal of Endocrinology|February 25, 2021
The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortalityMartina Behanova, Judith Haschka, Jochen Zwerina, et al.
Thrombosis and Haemostasis|December 24, 2003
The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosisHerwig Köppel, Wilfried Renner, Alexander Gugl, et al.
Thrombosis and Haemostasis|June 4, 2004
Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial diseaseHerwig Köppel, Peter Krippl, Robert Gasser, et al.
Stroke|March 8, 2003
Associations of a human G protein beta3 subunit dimorphism with insulin resistance and carotid atherosclerosisThomas C Wascher, Bernhard Paulweber, Liliane Malaimare, et al.
Diabetes Care|June 28, 2006
Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-alpha antibody infliximab: a case observationBabak Yazdani-Biuki, Thomas Mueller, Hans-Peter Brezinschek, et al.
International Journal of Cardiology|January 3, 2009
Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose toleranceSabine Perl, Isabella Schmölzer, Harald Sourij, et al.
Pageof 8